MBTD1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.155600E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.598800E-01
Normal-vs-Stage2
4.083800E-03
Normal-vs-Stage3
1.094200E-01
Normal-vs-Stage4
2.925000E-01
Stage1-vs-Stage2
1.491360E-01
Stage1-vs-Stage3
3.319900E-02
Stage1-vs-Stage4
9.119600E-01
Stage2-vs-Stage3
7.325600E-02
Stage2-vs-Stage4
3.033800E-01
Stage3-vs-Stage4
4.729900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.458900E-03
Normal-vs-AfricanAmerican
5.776000E-02
Normal-vs-Asian
1.270150E-02
Caucasian-vs-AfricanAmerican
9.349400E-01
Caucasian-vs-Asian
3.910400E-01
AfricanAmerican-vs-Asian
4.812800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.859080E-03
Normal-vs-Female
9.758700E-03
Male-vs-Female
1.417210E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.155000E-01
Normal-vs-Age(41-60Yrs)
3.536400E-02
Normal-vs-Age(61-80Yrs)
8.014000E-04
Normal-vs-Age(81-100Yrs)
1.605520E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.654000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.883800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.959600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.644280E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.196800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.927000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.845830E-01
Normal-vs-Daily Drinker
1.558570E-01
Normal-vs-Weekly Drinker
5.315700E-03
Normal-vs-Occasional Drinker
1.492820E-01
Normal-vs-Social Drinker
7.761700E-02
Non Drinker-vs-Daily Drinker
2.783800E-01
Non Drinker-vs-Weekly Drinker
3.390400E-01
Non Drinker-vs-Occasional Drinker
1.304190E-01
Non Drinker-vs-Social Drinker
2.900100E-02
Daily Drinker-vs-Weekly Drinker
9.489600E-01
Daily Drinker-vs-Occasional Drinker
4.085800E-02
Daily Drinker-vs-Social Drinker
6.881400E-03
Weekly Drinker-vs-Occasional Drinker
6.979600E-02
Weekly Drinker-vs-Social Drinker
2.372100E-02
Occasional Drinker-vs-Social Drinker
9.339600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.826300E-02
Normal-vs-Grade 2
1.799650E-02
Normal-vs-Grade 3
2.115500E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.871000E-01
Grade 1-vs-Grade 3
9.858800E-01
Grade 1-vs-Grade 4
2.826300E-02
Grade 2-vs-Grade 3
5.009800E-01
Grade 2-vs-Grade 4
1.799650E-02
Grade 3-vs-Grade 4
2.115500E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.562800E-04
Normal-vs-NonDiabetic
3.139300E-03
Diabetic-vs-NonDiabetic
1.172810E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.255900E-03
Normal-vs-NoPancreatitis
2.195700E-03
Pancreatitis-vs-NoPancreatitis
2.598400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.740400E-02
Normal-vs-N1
1.263410E-03
N0-vs-N1
6.778000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.538200E-01
Normal-vs-TP53-NonMutant
3.880000E-01
TP53-Mutant-vs-TP53-NonMutant
5.685000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
